REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 49 filers reported holding REGULUS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $123,000 | -3.1% | 37,144 | -15.7% | 0.00% | 0.0% |
| Q2 2016 | $127,000 | -56.8% | 44,037 | +3.7% | 0.00% | -50.0% |
| Q1 2016 | $294,000 | -27.0% | 42,476 | -8.1% | 0.00% | -20.0% |
| Q4 2015 | $403,000 | +45.5% | 46,212 | +9.2% | 0.01% | +25.0% |
| Q3 2015 | $277,000 | -43.0% | 42,302 | -4.6% | 0.00% | -42.9% |
| Q2 2015 | $486,000 | -34.3% | 44,333 | +1.5% | 0.01% | -22.2% |
| Q1 2015 | $740,000 | +30.1% | 43,671 | +23.0% | 0.01% | +28.6% |
| Q4 2014 | $569,000 | +199.5% | 35,494 | +27.6% | 0.01% | +133.3% |
| Q3 2014 | $190,000 | -28.3% | 27,809 | -15.8% | 0.00% | 0.0% |
| Q2 2014 | $265,000 | -32.2% | 33,009 | -23.9% | 0.00% | -40.0% |
| Q1 2014 | $391,000 | +177.3% | 43,394 | +127.5% | 0.01% | +150.0% |
| Q4 2013 | $141,000 | – | 19,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,590,688 | $60,826,000 | 6.04% |
| Foresite Capital Management II, LLC | 429,723 | $7,280,000 | 4.31% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,287,150 | $21,804,000 | 2.77% |
| Abingworth LLP | 327,350 | $5,542,000 | 2.36% |
| Cormorant Asset Management, LP | 896,522 | $15,187,000 | 2.35% |
| Trellus Management Company, LLC | 34,736 | $588,000 | 0.70% |
| AWM Investment Company, Inc. | 125,000 | $2,117,000 | 0.29% |
| BOURGEON CAPITAL MANAGEMENT LLC | 20,260 | $343,000 | 0.21% |
| Traynor Capital Management, Inc. | 11,550 | $195,000 | 0.19% |
| SABBY MANAGEMENT, LLC | 260,930 | $4,420,000 | 0.18% |